中文
Log in
List of Endocrine Disrupting Chemicals in France
Add to My Tools
More Inventories
Entries: 128
Items: 128
Last update: Oct 12, 2023
Entry number
CAS number
Original name of substance
EC No.
Details
1
4247-02-3
Isobutyl 4-hydroxybenzoate
224-208-8
More
2
80-09-1
4,4’-sulphonyldiphenol
201-250-5
More
3
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one covering any of the individual isomers and/or combinations thereof (4-MBC)
-
More
4
36861-47-9
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
253-242-6
More
5
1782069-81-1
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
-
More
6
95342-41-9
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
-
More
7
852541-30-1
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
-
More
8
852541-21-0
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
-
More
9
741687-98-9
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
-
More
10
852541-25-4
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
-
More
List of Endocrine Disrupting Chemicals in France
On October 12, 2023, France published an official decree on the requirements for endocrine-disrupting substances. The decree specifies a list of substances with endocrine-disrupting properties, and substances confirmed and suspected to be endocrine disruptors are listed in Annex I of the decree, in Table A and Table A bis (covering 128 substances, including 126 SVHC substances, cholecalciferol (vitamin D3) and mancozeb). Substances suspected to be endocrine disruptors are listed in Table B and Table B bis of Annex I (Table B and Table B bis are currently empty).
Disclaimers
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline